home / stock / halb / halb news


HALB News and Press, Tykhe Corp From 10/01/20

Stock Information

Company Name: Tykhe Corp
Stock Symbol: HALB
Market: OTC
Website: halberdcorporation.com

Menu

HALB HALB Quote HALB Short HALB News HALB Articles HALB Message Board
Get HALB Alerts

News, Short Squeeze, Breakout and More Instantly...

HALB - Halberd COVID-19 Preventative Nasal Spray Provisional Patent Application Filed

JACKSON CENTER, PA / ACCESSWIRE / October 1, 2020 / Halberd Corporation (OTC PINK: HALB ) announced they have obtained world-wide license to a provisional patent application covering a nasal spray to be used as a prevention measure against coronavirus. The provisional patent, " Nasal Spray T...

HALB - Arizona State University/Halberd Pursue Nasal Spray as COVID-19 Preventative/Treatment Based on Children's Natural Immunity

JACKSON CENTER, PA / ACCESSWIRE / September 28, 2020 / Children are far less susceptible than adults to the Coronavirus ( 1 , 2 ). Halberd Corporation's (OTC PINK: HALB ) scientists have determined the reason may be that adults have far more Angiotensin-Converting Enzyme 2 (ACE2) receptors ...

HALB - Arizona State University/Halberd Corp. Covid-19 R&D Program Rapid Diagnostic Test/Treatment

JACKSON CENTER, PA / ACCESSWIRE / September 24, 2020 / Halberd Corporation (OTC PINK: HALB ) clarifies next steps in their unique research with Arizona State University. Halberd directed their research program to focus on that element of Covid-19 which makes the disease most contagious - the...

HALB - Arizona State University/Halberd Corp. Covid-19 Research Program Progress - Successful Covid Spike Protein Disease Antigen Re-Creation!

JACKSON CENTER, PA / ACCESSWIRE / September 21, 2020 / Halberd Corporation (OTC PINK: HALB ) released a progress update on the research being conducted in conjunction with Arizona State University researchers. Dr. Qiang Chen, ASU's lead researcher, reports the successful re-creation of the c...

HALB - Arizona State University/Halberd Corp. Outline Partnership 2nd Stage Goals of $1.4 M Covid-19 Program

JACKSON CENTER, PA / ACCESSWIRE / September 17, 2020 / Halberd Corporation (OTC PINK: HALB ) today outlined the specifics of the second stage goals of the $1.4 Million seven-phase research project with Arizona State University. The second stage of the research involves an investigation of a...

HALB - Halberd Corporation Outlines Multi-Phase $1.4 M Covid-19 Program in Partnership With ASU

JACKSON CENTER, PA / ACCESSWIRE / September 14, 2020 / Halberd Corporation (OTC PINK: HALB ) today released the specifics of the initial phase of the $1.4 Million seven-phase research project with Arizona State University. The University project for a rapid test to identify Covid-19 infecti...

HALB - Halberd Corporation Research on Covid-19 Treatment Development Begins at ASU

Halberd Corporation Research on Covid-19 Treatment Development Begins at ASU JACKSON CENTER, PA / ACCESSWIRE / September 8, 2020 / Halberd Corporation (OTC PINK: HALB ) today announced Arizona State University (ASU) commenced its research work for Halberd Corp. The initial phases of ASU...

HALB - This Week on MoneyTV with Donald Baillargeon, 9/4

HOLLYWOOD, CA / ACCESSWIRE / September 4, 2020 / Covid-19 research, wireless activation, solar, hemp, anger healing, racial justice; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, ( http://...

HALB - Why Halberd Corporation Selected ASU And Where They Stand Among Other Universities

JACKSON CENTER, PA / ACCESSWIRE / September 2, 2020 / Halberd Corporation (OTC PINK: HALB ) today revealed why they selected Arizona State University (ASU) to conduct sponsored research to develop a Covid-19 treatment. ASU is one of the fastest growing research universities in the country a...

HALB - Halberd Selects Arizona State University (ASU) to Develop Its Patented COVID-19 Treatment(s)

JACKSON CENTER, PA / ACCESSWIRE / August 31, 2020 / Halberd Corporation (OTC PINK: HALB ) today announced the signing of a development agreement with Arizona State University (ASU) to conduct sponsored research to develop Halberd's Covid-19 treatments. The work will focus on developing antib...

Previous 10 Next 10